Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting.

Bifulco K, Longanesi-Cattani I, Liguori E, Arra C, Rea D, Masucci MT, De Rosa M, Pavone V, Stoppelli MP, Carriero MV.

Mol Cancer Ther. 2013 Oct;12(10):1981-93. doi: 10.1158/1535-7163.MCT-13-0077. Epub 2013 Aug 12.

2.

Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.

Bifulco K, Longanesi-Cattani I, Franco P, Pavone V, Mugione P, Di Carluccio G, Masucci MT, Arra C, Pirozzi G, Stoppelli MP, Carriero MV.

PLoS One. 2012;7(9):e44806. doi: 10.1371/journal.pone.0044806. Epub 2012 Sep 25.

3.

Regulation of cell migration and invasion by specific modules of uPA: mechanistic insights and specific inhibitors.

Carriero MV, Franco P, Votta G, Longanesi-Cattani I, Vento MT, Masucci MT, Mancini A, Caputi M, Iaccarino I, Stoppelli MP.

Curr Drug Targets. 2011 Nov;12(12):1761-71. Review.

PMID:
21707476
4.

Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization.

Bifulco K, Longanesi-Cattani I, Masucci MT, De Chiara A, Fazioli F, Di Carluccio G, Pirozzi G, Gallo M, La Rocca A, Apice G, Rocco G, Carriero MV.

Sarcoma. 2011;2011:842842. doi: 10.1155/2011/842842. Epub 2010 Dec 30.

5.

The soluble form of urokinase receptor promotes angiogenesis through its Ser⁸⁸-Arg-Ser-Arg-Tyr⁹² chemotactic sequence.

Bifulco K, Longanesi-Cattani I, Gala M, DI Carluccio G, Masucci MT, Pavone V, Lista L, Arra C, Stoppelli MP, Carriero MV.

J Thromb Haemost. 2010 Dec;8(12):2789-99. doi: 10.1111/j.1538-7836.2010.04075.x.

6.

Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis.

Carriero MV, Longanesi-Cattani I, Bifulco K, Maglio O, Lista L, Barbieri A, Votta G, Masucci MT, Arra C, Franco R, De Rosa M, Stoppelli MP, Pavone V.

Mol Cancer Ther. 2009 Sep;8(9):2708-17. doi: 10.1158/1535-7163.MCT-09-0174. Epub 2009 Aug 25.

7.

A conditioned medium from a human liposarcoma-derived cell line induces p53-dependent apoptosis in several tumor cell lines.

Mancini A, Borrelli A, Masucci MT, Schiattarella A, Filice S, Rashan J, Maggino T.

Oncol Rep. 2000 May-Jun;7(3):629-37.

PMID:
10767381
8.

Establishment and growth regulation of a novel ovarian cancer cell line from a poorly-differentiated adenocarcinoma: proposal for a new treatment.

Mancini A, Borrelli A, Formisano S, Masucci MT, Maffeo A, Perla G, De Martino L, Bevilacqua N, Botti G, Maggino T.

Eur J Gynaecol Oncol. 1999;20(1):45-52.

PMID:
10422682
9.

In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.

Ossowski L, Clunie G, Masucci MT, Blasi F.

J Cell Biol. 1991 Nov;115(4):1107-12.

10.

Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.

Quax PH, Pedersen N, Masucci MT, Weening-Verhoeff EJ, Danø K, Verheijen JH, Blasi F.

Cell Regul. 1991 Oct;2(10):793-803.

11.

A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor.

Masucci MT, Pedersen N, Blasi F.

J Biol Chem. 1991 May 15;266(14):8655-8.

12.

The urokinase receptor and regulation of cell surface plasminogen activation.

Blasi F, Behrendt N, Cubellis MV, Ellis V, Lund LR, Masucci MT, Møller LB, Olson DP, Pedersen N, Ploug M, et al.

Cell Differ Dev. 1990 Dec 2;32(3):247-53. Review. No abstract available.

PMID:
1965953
13.

Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.

Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, Appella E, Blasi F.

EMBO J. 1990 Feb;9(2):467-74. Erratum in: EMBO J 1990 May;9(5):1674.

14.

The receptor for human urokinase: a potential target for anti-invasive and anti-metastatic therapy.

Masucci MT, Blasi F.

Thromb Res Suppl. 1990;11:49-60. Review. No abstract available.

PMID:
2177576
15.

"4S" polycyclic aromatic hydrocarbon binding protein. Its role as a benzo(a) pyrene cytosolic carrier to the microsomes of DBA/2N mouse liver.

Masucci MT, Masi C, Martini E, Maiello C, Papaleo G, Sica V.

Tumori. 1989 Jun 30;75(3):211-6.

PMID:
2773072
16.

Purification to homogeneity of the major "4S" PAH binding protein from "non responsive" DBA/2N mouse liver by affinity chromatography.

Masucci MT, Masi C, Martini E, Maiello C, Papaleo G, Sica V.

Tumori. 1989 Jun 30;75(3):202-10.

PMID:
2773071
17.
18.

[Correlation between hormonal receptors and grading in tumors of the digestive system].

Contieri E, Liguori G, De Rosa G, Di Prisco D, Bevilacqua AM, Tatangelo F, Masucci MT, Sica V.

Minerva Chir. 1986 Mar 31;41(5-6):431-3. Italian. No abstract available.

PMID:
3725072
19.
20.

Interaction of rat liver glucocorticoid receptor with heparin.

Weisz A, Puca GA, Masucci MT, Masi C, Pagnotta R, Petrillo A, Sica V.

Biochemistry. 1984 Nov 6;23(23):5393-7.

PMID:
6509026
21.

Estradiol and progesterone receptors in malignant gastrointestinal tumors.

Sica V, Nola E, Contieri E, Bova R, Masucci MT, Medici N, Petrillo A, Weisz A, Molinari AM, Puca GA.

Cancer Res. 1984 Oct;44(10):4670-4.

Supplemental Content

Loading ...
Support Center